← Open Payments lookup

SACHA DEGRAFFENREID-YATES: Open Payments

NPI 1275088437 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,336 in 129 payments from 17 companies in 2025. Trend: 2023 $1,199 · 2024 $2,005 · 2025 $2,336

Food & beverage: $2,243Education: $93
CompanyPaymentsAmount
Amgen Inc.33$403
UCB, Inc.18$323
GlaxoSmithKline, LLC.19$318
PFIZER INC.12$230
E.R. Squibb & Sons, L.L.C.9$198
AstraZeneca Pharmaceuticals LP7$167
Novartis Pharmaceuticals Corporation8$152
GENZYME CORPORATION6$144
CSL Behring4$82
ABBVIE INC.3$78

Products named: Bimzelx, DUPIXENT, ORENCIA, XELJANZ, BENLYSTA, OTEZLA, NUCALA, COSENTYX.

Industry payments across MO — which companies pay providers there.